U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Tue Apr 01 21:26:41 GMT 2025
Edited
by admin
on Tue Apr 01 21:26:41 GMT 2025
Protein Type TRANSPORTER
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
F202H3PMO2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DA TRANSPORTER
Preferred Name English
SODIUM-DEPENDENT DOPAMINE TRANSPORTER
Common Name English
DAT
Common Name English
SLC6A3
Common Name English
SOLUTE CARRIER FAMILY 6 MEMBER 3
Common Name English
DAT1
Common Name English
Code System Code Type Description
CAS
816154-03-7
Created by admin on Tue Apr 01 21:26:41 GMT 2025 , Edited by admin on Tue Apr 01 21:26:41 GMT 2025
PRIMARY
FDA UNII
F202H3PMO2
Created by admin on Tue Apr 01 21:26:41 GMT 2025 , Edited by admin on Tue Apr 01 21:26:41 GMT 2025
PRIMARY
WIKIPEDIA
Dopamine transporter
Created by admin on Tue Apr 01 21:26:41 GMT 2025 , Edited by admin on Tue Apr 01 21:26:41 GMT 2025
PRIMARY
UNIPROT
Q01959
Created by admin on Tue Apr 01 21:26:41 GMT 2025 , Edited by admin on Tue Apr 01 21:26:41 GMT 2025
PRIMARY
From To
1_180 1_189
1_306 2_306
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_181
N 1_188
N 1_205
N 2_181
N 2_188
N 2_205
Related Record Type Details
Structure of MDMC
INHIBITOR -> TARGET
Structure of PSEUDOEPHEDRINE
INHIBITOR -> TARGET
Structure of RTI-120
INHIBITOR -> TRANSPORTER
Structure of BUTYLONE
INHIBITOR -> TARGET
IC50
Structure of RTI-150
INHIBITOR -> TRANSPORTER
Structure of RTI-112
INHIBITOR -> TRANSPORTER
IN-VITRO
Structure of JZ-IV-10
INHIBITOR -> TRANSPORTER
Structure of VANOXERINE
INHIBITOR -> TARGET
BINDING
IC50
Structure of RTI-113
INHIBITOR -> TRANSPORTER
Structure of 3-Chloro-PCP
INHIBITOR -> TARGET
Structure of INDOPAN
INHIBITOR -> TARGET
From Rat Membrane Studies
Structure of DOPAMINE
SUBSTRATE -> TRANSPORTER
BINDING
IC50
Structure of MEPHEDRONE
INHIBITOR -> TARGET
IC50
Structure of 2-BUTYL-3-(4-CHLOROPHENYL)-1-AZABICYCLO(2.2.2)OCT-2-ENE
INHIBITOR -> TARGET
Structure of (+)-.ALPHA.,.ALPHA.-DIPHENYL-2-PYRROLIDINEMETHANOL
INHIBITOR -> TARGET
Inhibition of [3H]Dopamine(100 uM) uptake in CHO cells expressing human dopamine transporter.
Ki
Structure of Solriamfetol
INHIBITOR -> TARGET
Ki
Structure of WIN-35428 O-C-11
RADIOLIGAND->TARGET
Structure of WY-46824
INHIBITOR -> TRANSPORTER
Structure of 4-(4-Chlorophenyl)-1-methyl-3-propylpiperidine, (3S,4S)-
INHIBITOR -> TRANSPORTER
Structure of PE-2I I-125
RADIOLIGAND->TARGET
Structure of 3-FLUORO-.ALPHA.-PVP
INHIBITOR -> TARGET
Structure of RTI-177
INHIBITOR -> TRANSPORTER
Structure of NIRAPARIB
INHIBITOR->OFF-TARGET
BINDING
IC50
Structure of PRC200-SS
INHIBITOR -> TRANSPORTER
Structure of RTI-371 FREE BASE
INHIBITOR -> TRANSPORTER
IN-VITRO
Structure of FE-PE2I F-18
RADIOLIGAND->TARGET
Ki
Structure of MODAFINIL
INHIBITOR -> TARGET
Structure of WIN-35428 N-C-11
RADIOLIGAND->TARGET
Structure of WF-23
INHIBITOR -> TARGET
Structure of NIRAPARIB
INHIBITOR -> TARGET
IN-VITRO
IC50
Structure of EMD-386088
INHIBITOR -> TRANSPORTER
Structure of Benocyclidine H-3
RADIOLIGAND->TARGET
Kd
Structure of 1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine
INHIBITOR -> TRANSPORTER
Structure of 3-METHYL-PCPY
INHIBITOR -> TRANSPORTER
Structure of MIDOMAFETAMINE, (R)-
NON-INHIBITOR->OFF TARGET
IC50
Structure of PF-4800567
INHIBITOR -> TRANSPORTER
Structure of Vortioxetine
NON-INHIBITOR->OFF TARGET
BINDING
Ki
Structure of MIDOMAFETAMINE
INHIBITOR -> TARGET
Inhibition of [3H]Neurotransmitter Uptake
IC50
Structure of NOMIFENSINE
INHIBITOR -> TARGET
Due to a risk of haemolytic anaemia, the U.S. Food and Drug Administration (FDA) withdrew approval for nomifensine on March 20, 1992. Nomifensine was subsequently withdrawn from the Canadian and UK markets as well.
BINDING
IC50
Structure of 2-BUTYL-3-(P-TOLYL)QUINUCLIDINE, (-)-
INHIBITOR -> TARGET
Structure of IOFLUPANE I-123
INHIBITOR -> TARGET
BINDING
IC50
Structure of 6-METHYL-MDA
INHIBITOR -> TRANSPORTER
IN RAT
Structure of 2-BUTYL-3-(4-METHYLPHENYL)-1-AZABICYCLO(2.2.2)OCT-2-ENE
INHIBITOR -> TARGET
Structure of CE-123
INHIBITOR -> TARGET
IC50
Structure of 2-BUTYL-3-(P-TOLYL)QUINUCLIDINE HYDROCHLORIDE, (-)-
INHIBITOR -> TARGET
Structure of Iometopane C-11
RADIOLIGAND->TARGET
Structure of CE-123, (S)-
INHIBITOR -> TARGET
IC50
Structure of 2-BUTYL-3-(P-TOLYL)QUINUCLIDINE
INHIBITOR -> TARGET
Structure of DEXMETHYLPHENIDATE
INHIBITOR -> TARGET
Structure of ARMODAFINIL
INHIBITOR -> TARGET
Structure of DIPHENYLPROLINOL
INHIBITOR -> TARGET
Structure of .ALPHA.-PCYP
INHIBITOR -> TARGET
Structure of BENOCYCLIDINE
INHIBITOR -> TARGET
BINDING
IC50
Structure of 4-Fluoropethidine
INHIBITOR -> TRANSPORTER
Structure of Pudafensine
INHIBITOR -> TARGET
IC50
Structure of 2'-HYDROXYCOCAINE
LIGAND->TRANSPORTER
Structure of TECHNETIUM TC-99M TRODAT-1
RADIOLIGAND->TARGET
Structure of 6-APB
INHIBITOR -> TARGET
IC50
Structure of WIN-35428 H-3
RADIOLIGAND->TARGET
Binds to cocaine binding site of human dopamine transporter
Structure of 5-APB
INHIBITOR -> TARGET
Ki
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966